Metastasized Kidney Cancer: Treatment Options Without Surgery
The beginning of the 2000s saw the birth of new treatments with the hope of limiting or even eradicating the development of solid cancers. These targeted therapies are aimed at preventing the tumor from building a network of blood vessels dedicated to its supply of oxygen and nutrients. Thus, deprived of food and energy, the cancer cells could no longer proliferate and eventually perish. Let’s see some of these treatments:
When tumors are small (<4 cm) or when surgery is not possible, especially in the elderly, low-invasive techniques are done by Renal cancer specialist in Delhi.
Anti-angiogenic treatments decrease the formation of blood vessels around metastases or tumor cells that have escaped the operation. They thus prevent the blood from reaching them and consequently they choke the cancer cells which no longer multiply and are gradually destroyed.
mTOR inhibitors are targeting one of the mechanisms responsible for the abnormal multiplication of cancer cells. There are currently two mTOR inhibitors: Temsirolimus (treatment for injection) and everolimus (oral treatment)
Radiofrequency treatment involves applying electromagnetic rays directly to the tumor. These rays heat and destroy cancer cells. The emitting probe is introduced through the skin, facing the kidney, and then conducted until the contact of the tumor under radiological control (ultrasound or scanner).
Cryo-ablation uses the same procedure, but the radio electric probe is replaced by a source that freezes the tumor tissue. This fabric will be gradually destroyed by heating.
Active monitoring by Renal Cancer Specialist in Delhi involves very regular monitoring of the tumor by a series of examinations and by medically or surgically intervening only when cancer progresses while remaining curable. This alternative is offered to the most delicate subjects (due to their age, or due to associated diseases) as well as to patients with a tiny tumor (<2 cm).
In kidney cancer, immunotherapy uses interleukin 2 (IL-2) and interferon alpha (IFN) alone or in combination. Their efficacy and tolerance are average. They are less used today than in the past (especially IL-2), but they remain indicated in certain clinical contexts, such as tumors with metastasis in the pulmonary level, in patients in good general condition.
You can visit BLK Super Specialty Hospital to consult Dr. Aditya Pradhan for effective renal cancer treatment. For more information visit- http://www.drpradhanurologist.com